Notable Analyst Rating Changes 6/25: XRTX, DE, JCP, LM, SLM Upgraded; COP, RHT, HAL Downgraded Jun 25, 2009 10:06AM

UPGRADES:
Stifel Nicolaus and Baird upgrade Xyratex (Nasdaq: XRTX) to Buy and Outperform, respectively.

Goldman Sachs upgraded Deere & Co. (NYSE: DE) from Sell to Neutral, maintaining their $42 price target. The firm is citing an improved risk/reward.

JPMorgan upgrades J.C. Penney (NYSE: JCP) from Neutral ...


Pre-Open Movers 3/25: Monsanto (MON) Up on Raised Guidance, SiRF Technology (SIRF) Lower on Warning Mar 25, 2008 09:23AM

StreetInsider.com Pre-Open Movers:

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) 75% LOWER; announced that its Phase 3 clinical trial evaluating the Company's exclusively-licensed technology from the Mayo Clinic consisting of an intranasal antifungal lavage, SinuNase (topical amphotericin B 0.01% suspension) achieved, as anticipated, superior resolution of the cardinal symptoms of chronic sinusitis (CS), as compared to placebo control arm, however, the analysis of the unblinded primary endpoint data did not show the required level of statistical significance when comparing the SinuNase arm to the control arm.

SiRF Technology Holdings, Inc. (Nasdaq: SIRF) 21% LOWER; sees first fiscal quarter revenue of $60M to $62M revenue, compared to the prior expected range of $71M to $77M.

MGIC Investment Corporation (NYSE: MTG) 11% LOWER; agreed to sell ...